Let’s partner to transform medicine—
and succeed together
At Assembly Bio, we take pride in the ingenuity, agility and rigor we apply to the scientific research we do. As a result, we’ve built some of the most cutting-edge drug discovery platforms in biopharma today. Our R&D effort is strong. It can be even stronger with the right academic and corporate partnerships in place.
Assembly Bio and Gilead have entered into a long-term partnership and collaboration to research and develop next-generation virology therapies, including Assembly Bio’s current and future portfolio and two herpesvirus programs contributed by Gilead. Gilead will control research, development and commercialization of programs that it opts into, while Assembly Bio may elect to certain profit/cost share and co-promotion options in the US for such Gilead-optioned programs.
If your organization is interested in collaborating with Assembly Bio
on a potential research and development venture, please
contact us at: BD@assemblybio.com.